Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DehydraTECH-GLP-1
- Development stage
- Unknown
- Lead developer
- Lexaria Bioscience
- Modality
- Peptides, Small Molecules
- Administration
- Oral
01
Overview
Lexaria Bioscience's DehydraTECH-GLP-1 is an oral drug delivery formulation utilizing the patented DehydraTECH platform to enhance the bioavailability and gastrointestinal tolerability of Glucagon-like peptide 1 (GLP-1) receptor agonists. The platform is being applied to several established GLP-1 peptides, including semaglutide, liraglutide, and the dual GLP-1/GIP agonist tirzepatide. By improving oral delivery, DehydraTECH aims to provide a more convenient alternative to injections while potentially reducing side effects like nausea and vomiting. The program is currently being evaluated for metabolic and inflammatory conditions, including type 2 diabetes, obesity (weight loss), obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatohepatitis (MASH).
- Other names
- GLP-1 Peptide formulationsGLP1 Peptide formulationsGLP 1 Peptide formulationsDehydraTECH GLP-1 variants
02
Targets
Beyond the preview
Go deeper on DehydraTECH-GLP-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DehydraTECH-GLP-1.